Younossi et al. therefore developed the NASH diagnostics model that includes two apoptosis markers (apoptosis- and necrosis-derived CK18 fragments) and two adipokines (adiponectin and resistin) [57]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.